This brand name is authorized in Poland
The drug ESSELIV contains one active pharmaceutical ingredient (API):
|
1
Soybean phospholipids
UNII 1DI56QDM62 - LECITHIN, SOYBEAN
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A05BA | Liver therapy | A Alimentary tract and metabolism → A05 Bile and liver therapy → A05B Liver therapy, lipotropics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100108131, 100286157 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
